Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 36
Filtrar
1.
Nat Immunol ; 9(12): 1379-87, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18978795

RESUMO

The survival of transitional and mature B cells requires both the B cell antigen receptor (BCR) and BLyS receptor 3 (BR3), which suggests that these receptors send signals that are nonredundant or that engage in crosstalk with each other. Here we show that BCR signaling induced production of the nonclassical transcription factor NF-kappaB pathway substrate p100, which is required for transmission of BR3 signals and thus B cell survival. The capacity for sustained p100 production emerged during transitional B cell differentiation, the stage at which BCR signals begin to mediate survival rather than negative selection. Our findings identify a molecular mechanism for the reliance of primary B cells on continuous BR3 and BCR signaling, as well as for the gradual resistance to negative selection that is acquired during B cell maturation.


Assuntos
Fator Ativador de Células B/metabolismo , Linfócitos B/citologia , Diferenciação Celular/imunologia , NF-kappa B/metabolismo , Receptores de Antígenos de Linfócitos B/metabolismo , Transdução de Sinais/imunologia , Animais , Fator Ativador de Células B/imunologia , Linfócitos B/imunologia , Linhagem Celular , Sobrevivência Celular/imunologia , Citometria de Fluxo , Humanos , Immunoblotting , Camundongos , NF-kappa B/imunologia , Receptor Cross-Talk/imunologia , Receptores de Antígenos de Linfócitos B/imunologia
2.
Immunity ; 28(6): 729-31, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18549794

RESUMO

In this issue of Immunity, Chaturvedi et al. (2008) describe a mechanism for the bridging of innate and adaptive immune receptor functions. In their model, B cell-receptor signaling induces the fusion of Toll-like receptor 9 (TLR9)-containing endosomes with internalized signaling-competent BCR into autophagosomes.


Assuntos
Fagossomos/metabolismo , Receptores de Antígenos de Linfócitos B/metabolismo , Transdução de Sinais , Receptor Toll-Like 9/metabolismo , Animais , Autoimunidade , Humanos , Ativação Linfocitária , Fagossomos/imunologia , Receptores de Antígenos de Linfócitos B/imunologia , Receptor Toll-Like 9/imunologia
3.
Nat Rev Immunol ; 6(4): 283-94, 2006 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16557260

RESUMO

Studies carried out over the past few years provide strong support for the idea that Ig alpha-Ig beta-containing complexes such as the pre-B-cell receptor and the B-cell receptor can signal independently of ligand engagement, and this has been termed tonic signalling. In this Review, I discuss recent literature that is relevant to the potential mechanisms by which tonic signals are initiated and regulated, and discuss views on how tonic and ligand-dependent (aggregation-mediated) signalling differ. These mechanisms are relevant to the possibility that tonic signals generated through immunoreceptor tyrosine-based activation motif (ITAM)-containing proteins that are expressed by oncogenic viruses induce transformation in non-haematopoietic cells.


Assuntos
Glicoproteínas de Membrana/fisiologia , Receptores de Antígenos de Linfócitos B/fisiologia , Transdução de Sinais/fisiologia , Motivos de Aminoácidos/genética , Motivos de Aminoácidos/fisiologia , Sequência de Aminoácidos , Animais , Humanos , Microdomínios da Membrana/imunologia , Microdomínios da Membrana/fisiologia , Modelos Biológicos , Receptores de Células Precursoras de Linfócitos B , Agregação de Receptores/imunologia , Agregação de Receptores/fisiologia , Transdução de Sinais/imunologia , Quinases da Família src/fisiologia
4.
Immunol Rev ; 237(1): 264-83, 2010 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-20727041

RESUMO

The advent of therapies that specifically target the B-lymphocyte lineage in human disease has rejuvenated interest in the mechanistic biology by which B cells mediate autoimmunity. B cells have a multitude of effector functions including production of self-reactive antibodies, ability to present antigen to T lymphocytes in the context of costimulation, involvement in generation and maintenance of neo-organogenesis at sites of disease, and opposing function through production of both immunostimulatory and immunomodulatory cytokines. In this review, we first discuss the role of B cells in driving autoimmune diseases such as rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, and Sjögren's syndrome, and discuss how studies in these diseases have revealed differentially important roles for the multiple B-cell effector functions. These data reveal the complex and interrelated roles of B cells working in concert with other components of the innate and adaptive immune system to drive pathogenesis. We then focus on data from mouse and human in which B cells in the setting of disease have been targeted with drugs directed against CD20, CD22, and the BAFF (B-cell activating factor belonging to the tumor necrosis factor family)/APRIL (a proliferation inducing ligand) pathways. Pre-clinical studies in animal models in addition to and clinical trials targeting B cells have added further to the understanding of the differential roles B cells play in disease both through demonstration of clinical efficacy in the context of B-cell depletion or modulation, and also by failure of B-cell targeting in some diseases and disease patient subgroups. Moving forward, it will be imperative to apply these lessons to new interventional trials to ensure better targeting of the B-cell lineage and concomitantly better selection of patients most likely to benefit from these therapies.


Assuntos
Doenças Autoimunes/terapia , Linfócitos B/efeitos dos fármacos , Animais , Anticorpos Monoclonais Murinos/uso terapêutico , Doenças Autoimunes/tratamento farmacológico , Doenças Autoimunes/fisiopatologia , Linfócitos B/citologia , Linfócitos B/imunologia , Sistemas de Liberação de Medicamentos , Humanos , Fatores Imunológicos/uso terapêutico , Camundongos , Rituximab
5.
J Virol ; 86(24): 13232-40, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23015704

RESUMO

Many receptors in hematopoietic cells use a common signaling pathway that relies on a highly conserved immunoreceptor tyrosine-based activation motif (ITAM), which signals through Src family tyrosine kinases. ITAM-bearing proteins are also found in many oncogenic viruses, including the mouse mammary tumor virus (MMTV) envelope (Env). We previously showed that MMTV Env expression transformed normal mammary epithelial cells and that Src kinases were important mediators in this transformation. To study how ITAM signaling affects mammary cell transformation, we utilized mammary cell lines expressing two different ITAM-containing proteins, one encoding a MMTV provirus and the other a B cell receptor fusion protein. ITAM-expressing cells were resistant to both serum starvation- and chemotherapeutic drug-induced apoptosis, whereas cells transduced with these molecules bearing ITAM mutations were indistinguishable from untransduced cells in their sensitivity to these treatments. We also found that Src kinase was activated in the MMTV-expressing cells and that MMTV-induced apoptosis resistance was completely restored by the Src inhibitor PP2. In vivo, MMTV infection delayed involution-induced apoptosis in the mouse mammary gland. Our results show that MMTV suppresses apoptosis through ITAM-mediated Src tyrosine kinase signaling. These studies could lead to the development of effective treatment of nonhematopoietic cell cancers in which ITAM-mediated signaling plays a role.


Assuntos
Apoptose/fisiologia , Glândulas Mamárias Animais/citologia , Vírus do Tumor Mamário do Camundongo/fisiologia , Transdução de Sinais , Animais , Sequência de Bases , Linhagem Celular , Primers do DNA , Células Epiteliais/metabolismo , Glândulas Mamárias Animais/metabolismo , Camundongos , Camundongos Endogâmicos BALB C
6.
Arthritis Rheum ; 63(12): 3681-91, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22127691

RESUMO

OBJECTIVE: Rituximab significantly improves the signs and symptoms of rheumatoid arthritis (RA) and slows the progression of joint damage. The aim of this study was to identify clinical characteristics and biomarkers that identify patients with RA in whom the clinical benefit of rituximab may be enhanced. METHODS: The study group comprised 1,008 RA patients from 2 independent randomized placebo-controlled phase III clinical trials (REFLEX [Randomized Evaluation of Long-Term Efficacy of Rituximab in Rheumatoid Arthritis] and SERENE [Study Evaluating Rituximab's Efficacy in Methotrexate Inadequate Responders]). A novel threshold selection method was used to identify baseline candidate biomarkers present in at least 20% of patients that enriched for placebo-corrected American College of Rheumatology 50% improvement (ACR50 response; a high clinical efficacy bar) at week 24 after the first course of rituximab. RESULTS: The presence of IgM rheumatoid factor (IgM-RF), IgG-RF, IgA-RF, and IgG anti-cyclic citrullinated peptide (anti-CCP) antibodies together with an elevated C-reactive protein (CRP) level were associated with enhanced placebo-corrected ACR50 response rates in the REFLEX patients with RA who had an inadequate response to anti-tumor necrosis factor therapies. These findings were independently replicated using samples from patients in SERENE who had an inadequate response to disease-modifying antirheumatic drug treatment. The combination of an elevated baseline CRP level together with an elevated level of any RF isotype and/or IgG anti-CCP antibodies was further associated with an enhanced benefit to rituximab. CONCLUSION: The presence of any RF isotype and/or IgG anti-CCP autoantibodies together with an elevated CRP level identifies a subgroup of patients with RA in whom the benefit of rituximab treatment may be enhanced. Although the clinical benefit of rituximab was greater in the biomarker-positive population compared with the biomarker-negative population, the clinical benefit of rituximab compared with placebo was also clinically meaningful in the biomarker-negative population.


Assuntos
Anticorpos Monoclonais Murinos/uso terapêutico , Artrite Reumatoide/tratamento farmacológico , Autoanticorpos/sangue , Proteína C-Reativa/metabolismo , Inflamação/sangue , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Antirreumáticos/uso terapêutico , Artrite Reumatoide/sangue , Biomarcadores/sangue , Método Duplo-Cego , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Peptídeos Cíclicos/imunologia , Fator Reumatoide/imunologia , Rituximab , Resultado do Tratamento , Adulto Jovem
7.
Front Immunol ; 13: 875320, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35615349

RESUMO

MALT1 forms part of a central signaling node downstream of immunoreceptor tyrosine-based activation motif (ITAM)-containing receptors, across a broad range of immune cell subsets, and regulates NF-κB driven transcriptional responses via dual scaffolding-protease activity. Allosteric inhibition of MALT1 activity has demonstrated benefit in animal models of inflammation. However, development of MALT1 inhibitors to treat autoimmune and inflammatory diseases (A&ID) has been hindered by reports linking MALT1 inhibition and genetic loss-of-function to reductions in regulatory T-cell (Treg) numbers and development of auto-inflammatory syndromes. Using an allosteric MALT1 inhibitor, we investigated the consequence of pharmacological inhibition of MALT1 on proinflammatory cells compared to regulatory T-cells. Consistent with its known role in ITAM-driven responses, MALT1 inhibition suppressed proinflammatory cytokine production from activated human T-cells and monocyte-derived macrophages, and attenuated B-cell proliferation. Oral administration of a MALT1 inhibitor reduced disease severity and synovial cytokine production in a rat collagen-induced arthritis model. Interestingly, reduction in splenic Treg numbers was less pronounced in the context of inflammation compared with naïve animals. Additionally, in the context of the disease model, we observed an uncoupling of anti-inflammatory effects of MALT1 inhibition from Treg reduction, with lower systemic concentrations of inhibitor needed to reduce disease severity compared to that required to reduce Treg numbers. MALT1 inhibition did not affect suppressive function of human Tregs in vitro. These data indicate that anti-inflammatory efficacy can be achieved with MALT1 inhibition without impacting the number or function of Tregs, further supporting the potential of MALT1 inhibition in the treatment of autoimmune disease.


Assuntos
Doenças Autoimunes , Proteína de Translocação 1 do Linfoma de Tecido Linfoide Associado à Mucosa , Linfócitos T Reguladores , Animais , Doenças Autoimunes/tratamento farmacológico , Doenças Autoimunes/patologia , Citocinas/genética , Inflamação , Ativação Linfocitária , Proteína de Translocação 1 do Linfoma de Tecido Linfoide Associado à Mucosa/antagonistas & inibidores , NF-kappa B , Ratos , Linfócitos T Reguladores/efeitos dos fármacos
8.
J Exp Med ; 201(3): 431-9, 2005 Feb 07.
Artigo em Inglês | MEDLINE | ID: mdl-15684322

RESUMO

Expression of immunoreceptor tyrosine-based activation motif (ITAM)-containing signaling proteins is normally restricted to hematopoietic tissues. The basal activity of ITAM-containing proteins is mediated through negative regulation by coreceptors restricted to hematopoietic tissues. We have identified an ITAM signaling domain encoded within the env gene of murine mammary tumor virus (MMTV). Three-dimensional structures derived in vitro from murine cells stably transfected with MMTV env display a depolarized morphology in comparison with control mammary epithelial cells. This effect is abolished by Y>F substitution within the Env ITAM, as well as inhibitors of Syk and Src protein tyrosine kinases. Env-expressing cells bear hallmarks of cell transformation such as sensitivity to apoptosis induced by tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) or TNFalpha, as well as down-regulation of E-cadherin and Keratin-18. Human normal mammary epithelial cells expressing MMTV Env also develop transformed phenotype, as typified by growth in soft agar and Matrigel invasion. These disruptions are abrogated by Y>F substitutions. We conclude that ITAM-dependent signals are generated through MMTV Env and trigger early hallmarks of transformation of mouse and human mammary epithelial cells. Therefore, these data suggest a heretofore unappreciated potential mechanism for the initiation of breast cancer and identify MMTV Env and ITAM-containing proteins in human breast tumors as probable oncoproteins.


Assuntos
Sequência de Aminoácidos , Neoplasias da Mama , Transformação Celular Viral , Células Epiteliais/fisiologia , Genes env , Vírus do Tumor Mamário do Camundongo/genética , Animais , Neoplasias da Mama/genética , Neoplasias da Mama/metabolismo , Técnicas de Cultura de Células , Linhagem Celular , Precursores Enzimáticos/metabolismo , Células Epiteliais/citologia , Feminino , Humanos , Peptídeos e Proteínas de Sinalização Intracelular , Glândulas Mamárias Animais/citologia , Glândulas Mamárias Animais/metabolismo , Vírus do Tumor Mamário do Camundongo/metabolismo , Camundongos , Dados de Sequência Molecular , Fenótipo , Proteínas Tirosina Quinases/metabolismo , Transdução de Sinais/fisiologia , Quinase Syk , Quinases da Família src/metabolismo
9.
J Clin Invest ; 117(9): 2602-10, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17717600

RESUMO

The presumed involvement of paired box gene 5 (PAX5) in B-lymphomagenesis is based largely on the discovery of Pax5-specific translocations and somatic hypermutations in non-Hodgkin lymphomas. Yet mechanistically, the contribution of Pax5 to neoplastic growth remains undeciphered. Here we used 2 Myc-induced mouse B lymphoma cell lines, Myc5-M5 and Myc5-M12, which spontaneously silence Pax5. Reconstitution of these cells with Pax5-tamoxifen receptor fusion protein (Pax5ER(TAM)) increased neoplastic growth in a hormone-dependent manner. Conversely, expression of dominant-negative Pax5 in murine lymphomas and Pax5 knockdown in human lymphomas negatively affected cell expansion. Expression profiling revealed that Pax5 was required to maintain mRNA levels of several crucial components of B cell receptor (BCR) signaling, including CD79a, a protein with the immunoreceptor tyrosine-based activation motif (ITAM). In contrast, expression of 2 known ITAM antagonists, CD22 and PIR-B, was suppressed. The key role of BCR/ITAM signaling in Pax5-dependent lymphomagenesis was corroborated in Syk, an ITAM-associated tyrosine kinase. Moreover, we observed consistent expression of phosphorylated BLNK, an activated BCR adaptor protein, in human B cell lymphomas. Thus, stimulation of neoplastic growth by Pax5 occurs through BCR and is sensitive to genetic and pharmacological inhibitors of this pathway.


Assuntos
Linfócitos B/imunologia , Linfócitos B/metabolismo , Linfoma/metabolismo , Linfoma/patologia , Fator de Transcrição PAX5/metabolismo , Receptores de Antígenos de Linfócitos B/metabolismo , Animais , Linhagem Celular Tumoral , Proliferação de Células , Transformação Celular Neoplásica/metabolismo , Transformação Celular Neoplásica/patologia , Regulação Neoplásica da Expressão Gênica , Humanos , Ativação Linfocitária/imunologia , Linfoma/genética , Linfoma/imunologia , Camundongos , Transplante de Neoplasias , Fator de Transcrição PAX5/genética , Transdução de Sinais
10.
J Immunol ; 181(7): 4590-602, 2008 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-18802061

RESUMO

Egr-1 (early growth response gene-1) is an immediate early gene encoding a zinc finger motif-containing transcription factor. Upon cross-linking of BCR, mature B cells undergo proliferation with an increase in Egr-1 message. Immature B lymphoma cells that express Egr-1 message and protein constitutively are growth inhibited when Egr-1 is down-regulated by negative signals from BCR or by antisense oligonucleotides. To test the hypothesis that Egr-1 is important for B cell development, we examined B cells from primary and secondary lymphoid organs in Egr-1(-/-) mice. Marginal zone B cell development was arrested in these mice, whereas the B cells in all other compartments were increased. To test the hypothesis that Egr-1 function may be partially compensated by other Egr family members, we developed transgenic mice expressing a dominant negative form of Egr-1, which lacks the trans activation domain but retains the DNA-binding domain, in a B cell-specific manner. There was a decrease in B lymphopoiesis in the bone marrow accompanied by a reduction in splenic immature and mature B cells as well as marginal zone B cells in the transgenic mice. Moreover, transgenic mice respond poorly to BCR cross-linking in vitro and T-independent and T-dependent Ags in vivo.


Assuntos
Linfócitos B/imunologia , Linfócitos B/metabolismo , Diferenciação Celular/imunologia , Proliferação de Células , Proteína 1 de Resposta de Crescimento Precoce/genética , Animais , Antígenos T-Independentes/fisiologia , Linfócitos B/citologia , Diferenciação Celular/genética , Linhagem Celular , Linhagem Celular Tumoral , Proteína 1 de Resposta de Crescimento Precoce/deficiência , Proteína 1 de Resposta de Crescimento Precoce/fisiologia , Feminino , Tecido Linfoide/citologia , Tecido Linfoide/imunologia , Tecido Linfoide/metabolismo , Linfopoese/genética , Linfopoese/imunologia , Camundongos , Camundongos Endogâmicos C3H , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos CBA , Camundongos Knockout , Camundongos Transgênicos , Receptores de Antígenos de Linfócitos B/fisiologia
11.
Adv Immunol ; 95: 1-50, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17869609

RESUMO

In adult mammals, bone marrow pluripotent hematopoietic stem cells generate B lymphoid-specified progeny that progress through a series of well-characterized stages before generating B-cell receptor expressing B lymphocytes. These functionally immature B lymphocytes then migrate to the spleen wherein they differentiate through transitional stages into follicular or marginal zone B lymphocytes capable of responding to T-dependent and -independent antigens, respectively. During the terminal stages of B lymphocyte development in the bone marrow, as well as immediately following egress into the peripheral compartments, B lymphocytes are counterselected to eliminate B lymphocytes with potentially dangerous self-reactivity. These developmental and selection events in the bone marrow and periphery are dependent on the integration of intrinsic genetic programs with extrinsic microenvironmental signals that drive progenitors toward increasing B lineage commitment and maturation. This chapter provides a comprehensive overview of the various stages of primary and secondary B lymphocyte development with an emphasis on the selection processes that affect decisions at critical checkpoints. Our intent is to stress the concept that at many steps in the developmental process leading to a mature immunocompetent B lymphocyte, B lineage cells are integrating multiple and different signaling inputs that are translated into specific and appropriate cell fate decisions.


Assuntos
Subpopulações de Linfócitos B/citologia , Linfócitos B/citologia , Linfopoese , Receptores de Antígenos de Linfócitos B/metabolismo , Envelhecimento , Animais , Antígenos de Diferenciação de Linfócitos B/análise , Subpopulações de Linfócitos B/imunologia , Subpopulações de Linfócitos B/fisiologia , Linfócitos B/imunologia , Linfócitos B/fisiologia , Células da Medula Óssea/citologia , Células da Medula Óssea/imunologia , Células da Medula Óssea/fisiologia , Linhagem da Célula , Humanos , Linfopoese/genética , Modelos Imunológicos , Células Precursoras de Linfócitos B/citologia , Células Precursoras de Linfócitos B/imunologia , Células Precursoras de Linfócitos B/fisiologia , Receptores de Antígenos de Linfócitos B/imunologia , Recombinação Genética , Transdução de Sinais
12.
Adv Exp Med Biol ; 640: 12-21, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-19065780

RESUMO

The subunit structure of the B-cell antigen receptor (BCR) and its associated compartmentalization of function confer enormous flexibility for generating signals and directing these toward specific and divergent cell fate decisions. Like all the multichain immune recognition receptors discussed in this volume, assembly of these multi-unit complexes sets these receptors apart from almost all other cell surface signal transduction proteins and affords them the ability to participate in almost all of the diverse aspects of, in this case, B-cell biology. We discuss here the structural aspects of the BCR and its associated coreceptors and relate these mechanistically to how BCR signaling can be directed towards specific fate decisions. By doing so, the BCR plays a pivotal role in ensuring the effective and appropriate B-cell response to antigen.


Assuntos
Receptores de Antígenos de Linfócitos B/imunologia , Animais , Linfócitos B/citologia , Compartimento Celular , Membrana Celular/imunologia , Humanos , Ligantes , Receptores de Antígenos de Linfócitos B/química , Transdução de Sinais
13.
Curr Opin Immunol ; 16(3): 288-95, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15134777

RESUMO

The random and inherently imprecise process of V(D)J recombination is the foundation for generation of the B-cell receptor (BCR). Signals must be generated to trigger selective processes that retain cells expressing a functional BCR, and these signals must be antigen-independent to insure an unbiased and diverse pool of newly formed B cells. Moreover, BCR expression, and presumably signaling, is essential for the continued survival of the B cell. Although BCR signaling is generally thought to depend upon ligand-induced aggregation, recent studies argue that some aspects of BCR signaling occur independently of antigen, and, furthermore, these non-induced or 'tonic' signals are linked to specific cellular processes operating at multiple stages of B-cell development. The potential co-existence of tonic and induced signaling suggests a unique aspect of BCR complexes, or at least an aspect of receptors that has previously been under-appreciated.


Assuntos
Linfócitos B/imunologia , Ativação Linfocitária/imunologia , Receptores de Antígenos de Linfócitos B/imunologia , Recombinação Genética/imunologia , Transdução de Sinais/imunologia , Animais , Proteínas de Ligação a DNA/genética , Proteínas de Ligação a DNA/imunologia , Humanos , Ativação Linfocitária/genética , Camundongos , Camundongos Knockout , Proteínas Nucleares , Recombinação Genética/genética , Transdução de Sinais/genética , VDJ Recombinases/genética , VDJ Recombinases/imunologia
14.
Transplantation ; 79(3 Suppl): S12-3, 2005 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-15699737

RESUMO

B cells play a critical role in the adaptive immune response to foreign antigen. In this case, they function both as antigen presenting cells for T cell activation and as secretors of antigen-specific antibodies. In contrast to foreign antigen, B cell responses to self-antigens are normally prevented by a variety of mechanisms collectively referred to as tolerance. Our studies have focused on defining the biochemical pathways involved in directing B cell antigen receptor-induced signals to processes leading to their elimination. We have found that protein kinase Cbeta plays a critical determining role in the differential signaling of B cells resulting in either tolerance or activation. These results suggest this enzyme as a potential target for manipulating the B cell response to foreign antigens.


Assuntos
Formação de Anticorpos/imunologia , Linfócitos B/imunologia , Tolerância Imunológica/imunologia , Animais , Apoptose , Linfócitos B/citologia , Linfócitos B/fisiologia , Humanos , Modelos Imunológicos
15.
Immunol Res ; 27(2-3): 427-42, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12857986

RESUMO

Our laboratory is interested in a variety of issues related to lymphocyte development. More specifically, we have focused on the processes that regulate the decision to commit to the B lymphocyte (B cell) lineage, then the subsequent signals that are involved in maintaining this commitment to the B cell lineage. These signals result in the positive selection of those B cells that properly execute the complex genetic changes associated with B cell development, then trigger the elimination of B cells that are responsive to self-antigens and, therefore, possess the potential to mediate autoimmune disease. Our general experimental approach has been to address these issues from the perspective of signal transduction. Our goal is to define the biochemical and genetic processes that are integrated in order to accomplish these selection processes. To do so, we employ in vivo animal models as well as more defined in vitro studies, using both primary and transformed cell lines. For the past several years, we have been primarily interested in the precise mechanisms by which the B cell antigen receptor (BCR), and intermediate forms of this receptor, regulate these complex developmental processes. We have used the ongoing studies described below as two representative examples of how we are approaching these issues and some of the insights that we have made. To place both of these studies in context, we will begin with a brief introduction into B cell development.


Assuntos
Linfócitos B/imunologia , Diferenciação Celular/imunologia , Linhagem da Célula/imunologia , Receptores de Antígenos de Linfócitos B/imunologia , Transdução de Sinais/imunologia , Animais , Humanos
17.
PLoS One ; 4(3): e4736, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19270748

RESUMO

TNF receptor superfamily members, such as CD40 and the Toll-like receptors (TLRs), regulate many aspects of B cell differentiation and activation. TRAF6 is an intracellular signaling adaptor molecule for these receptors, but its role in B cells has not been clarified by previous genetic approaches, as the systemic deletion of the TRAF6 gene results in perinatal lethality. Here we show that B cell-specific TRAF6 deficiency results in a reduced number of mature B cells in the bone marrow and spleen. Optimal T cell-dependent (TD) antigen responses, as characterized by isotype switching and long-lived plasma cell generation, are also impaired in B cell-specific TRAF6-deficient mice. B cell-specific TRAF6-deficient mice also exhibit lower levels of serum IgM and IgG2b and defective antigen-specific IgM production in response to T cell-independent (TI) antigens. Unexpectedly, TRAF6-deficient B cell progenitors are unable to generate CD5(+) B-1 cells. These results reveal critical roles for TRAF6 in TD and TI humoral immune responses and in inductive fate decisions necessary to generate the B-1 B cell compartment.


Assuntos
Linfócitos B/imunologia , Linfócitos T/imunologia , Fator 6 Associado a Receptor de TNF/fisiologia , Proteínas Adaptadoras de Transporte Vesicular/fisiologia , Animais , Linfócitos B/citologia , Linfócitos B/metabolismo , Antígenos CD40/fisiologia , Proliferação de Células , Citocinas/metabolismo , Ensaio de Imunoadsorção Enzimática , Eritrócitos/metabolismo , Citometria de Fluxo , Imunização , Immunoblotting , Imunoglobulina G/sangue , Imunoglobulina M/sangue , Integrases/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Fator 88 de Diferenciação Mieloide/fisiologia , NF-kappa B/metabolismo , Ovinos , Transdução de Sinais/imunologia , Linfócitos T/citologia , Linfócitos T/metabolismo
18.
J Immunol ; 179(7): 4464-72, 2007 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-17878342

RESUMO

The BCR-triggered responses of mature and transitional immature B cells differ at both the biochemical and functional level. In this study, we show that in mature B cells, BCR signaling triggers Vav phosphorylation and Rac1 activation. Furthermore, we demonstrate that although downstream actin-dependent BCR capping is independent of Rac1 activation, actin-dependent membrane ruffling and cell spreading are Rac1-dependent processes. In contrast, BCR-induced Vav phosphorylation and Rac1 activation is impaired in transitional immature B cells, resulting in defects in actin polymerization-dependent spreading and membrane ruffling while Rac1-independent BCR capping remains intact. Because transitional immature murine B cells maintain lower steady-state levels of plasma membrane cholesterol, we augmented their levels to that of mature B cells and found that BCR-induced Rac1 activation and Rac1-dependent membrane ruffling and cell spreading were restored. These studies provide a direct link between B cell cholesterol levels and downstream cellular signaling processes.


Assuntos
Linfócitos B/citologia , Linfócitos B/metabolismo , Diferenciação Celular , Membrana Celular/metabolismo , Colesterol/metabolismo , Receptores de Antígenos de Linfócitos B/metabolismo , Proteínas rac1 de Ligação ao GTP/metabolismo , Animais , Anticorpos/imunologia , Linfócitos B/imunologia , Células Cultivadas , Ativação Enzimática , Proteínas Quinases JNK Ativadas por Mitógeno/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Fenótipo , Proteínas Proto-Oncogênicas c-vav/metabolismo , Receptores de Antígenos de Linfócitos B/imunologia , Transdução de Sinais
19.
Immunol Rev ; 218: 214-34, 2007 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17624955

RESUMO

The presence of an immunoreceptor tyrosine-based activation motif (ITAM) makes immunoreceptors different from other signaling receptors, like integrins, G-coupled protein receptors, chemokine receptors, and growth factor receptors. This unique motif has the canonical sequence D/Ex(0-2)YxxL/Ix(6-8)YxxL/I, where x represents any amino acid and is present at least once in all immunoreceptor complexes. Immunoreceptors can promote survival, activation, and differentiation by transducing signals through these highly conserved motifs. Traditionally, ITAM signaling is thought to occur in response to ligand-induced aggregation, although evidence indicates that ligand-independent tonic signaling also provides functionally relevant signals. The majority of proteins containing ITAMs are transmembrane proteins that exist as part of immunoreceptor complexes. However, oncogenic viruses also have ITAM-containing proteins. In this review, we discuss what is known about tonic signaling by both cellular and viral ITAM-containing proteins and speculate what we might learn from each context.


Assuntos
Linfócitos B/imunologia , Linfócitos B/metabolismo , Receptores Imunológicos/imunologia , Receptores Imunológicos/metabolismo , Receptores Virais/imunologia , Receptores Virais/metabolismo , Transdução de Sinais/imunologia , Motivos de Aminoácidos , Animais , Humanos , Receptores Imunológicos/química , Receptores Virais/química , Tirosina/metabolismo
20.
Future Oncol ; 2(2): 301-10, 2006 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16563097

RESUMO

Cancer is thought to arise as a consequence of multiple insults to a cell. Mutations that lead to increased expression or activity of proto-oncogenes or decreased expression of tumor suppressors are common insults that have been identified to date. However, when considering tumor viruses, viral proteins that modify cellular gene expression, alter host immune surveillance, or affect signaling pathways are also common players. Notably, several of these tumor viruses encode proteins containing an immunoreceptor-associated tyrosine-based activation motif (ITAM), a signaling motif recently implicated in epithelial cell oncogenesis. As expression of proteins bearing this motif is normally restricted to hematopoietic cells, recent work highlighting the consequences of ITAM expression in epithelial cells suggests it may play a role in solid tumor formation.


Assuntos
Proteínas de Neoplasias/metabolismo , Receptores Imunológicos/metabolismo , Tirosina/metabolismo , Proteínas Virais/metabolismo , Motivos de Aminoácidos , Transformação Celular Neoplásica , Humanos , Fatores de Transcrição NFATC , Proteínas de Neoplasias/imunologia , Transdução de Sinais , Proteínas Virais/imunologia , Replicação Viral , Domínios de Homologia de src
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA